Saturday, August 1, 2026

U.S. and South Korea Set to Sign Major Defense Deal Amid Trump Concerns

South Korea and the U.S. will sign the 12th SMA this week, aiming to finalize defense cost-sharing before the election.

Kim Jong Un’s ‘Parental Love’ on Display During Flood Recovery Visit

North Korea's state-run newspaper praised its leader, Kim Jong Un, for visiting flood-stricken areas in Uiju County last week.

LG Electronics Showcases AI-Powered Commercial Laundry Solutions at Clean Show 2025

LG Electronics showcases AI-driven commercial laundry solutions at Clean Show 2025, targeting growth in North America and Europe.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

Seers wins FDA clearance for wearable ECG device, accelerating U.S. expansion

Seers' mobiCARE™ ECG monitor received FDA clearance, accelerating U.S. market entry and enhancing global expansion plans.

Continuous glucose monitors linked to 62% lower risk of death in Type 1 diabetes patients, study finds

A Korean study shows continuous glucose monitoring significantly reduces complications and mortality in Type 1 diabetes patients.

Top 10 Breakthrough Research Projects from the 2026 UST Proposal Challenge

UST's Proposal Challenge showcased innovative student research aimed at solving social issues, with awards for top proposals in various fields.

Understanding Iron Deficiency Anemia: Symptoms, Risks, and Prevention Tips

Anemia, especially iron deficiency, can lead to fatigue and serious health issues. Early diagnosis and treatment are crucial.

Korea Rising: How South Korea is Shaping the Future of the Global Bioindustry at BIO International Convention 2026

Korea's bioindustry showcased its innovations at BIO USA 2026, emphasizing global collaboration and the need for diverse business models.

‘Mom, Dad’ and Ball Kicks…’Human Theater’ Quintuplets Show Remarkable Growth

Quintuplets born prematurely at 27 weeks show healthy development at 18 months, thanks to dedicated care and monitoring.

[Lillie report] Lilly’s Pacific-facing innovation hub brings K-biotech future to Songdo

Lilly Gateway Labs in San Diego supports early-stage biotechs, expanding to Korea with Samsung Biologics to foster innovation.

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

Partnering Hits 180 Meetings, 2,000 Visitors…Celltrion Showcases AI and ADC Strength at BIO USA

Celltrion showcased AI-driven drug development at BIO USA, holding 180 meetings and emphasizing partnerships in antibody programs.

Big Pharma Turns to AI, China to Capital—What K-Bio Faced in San Diego [BIO USA Wrap-Up]

The BIO International Convention 2026 highlighted AI's role in biotech, emphasizing supply chain shifts and the need for capital investment.

GCCL Strengthens Global Clinical Trial Role: What This Means for Asia’s Biotech Industry?

GCCL aims to expand internationally as a central lab for clinical trials, enhancing services and leveraging competitive advantages.

Revolutionizing Healthcare: How Low-Risk NK Cell Therapy is Changing Regenerative Medicine in 2026

The Ministry of Health reclassifies autologous immune cell cultivation as low risk, expediting treatment access while ensuring safety.

Lotte Biologics says it has secured top-10 global CDMO manufacturing capacity [BIO USA]

Lotte Biologics is set to begin commercial production by the end of 2026, advancing its capabilities in the global CDMO market.

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.